A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma

NCT00452699 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

621

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone Propionate/salmeterol xinofoate 250/50 mcg BID
DRUG: Fluticasone propionate 250 mcg BID

Sponsor

GlaxoSmithKline